First treatment for cluster headaches approved in US
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.
List view / Grid view
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
A research team from Scripps Research Translational Institute has published revealing figures in relation to drug prices in the US.
New briefing documents provide policy recommendations to help the EU tackle high medicines prices brought about by market monopolies.
Thermo Scientific Orbitrap Exploris 480 mass spectrometer designed for high-throughput biopharmaceutical and academic research laboratories.
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
Heritage has recalled two of its injectable treatments after microbial growths were found.
GlaxoSmithKline (GSK) has been given Chinese approval for its shingles vaccine.